Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
Taiwan · Delayed Price · Currency is TWD 22.15
+0.15 (0.68%)
Apr 17, 2026, 1:12 PM CST
TPEX:6704 Revenue
In the year 2025, Gwo Xi Stem Cell Applied Technology Co. , had annual revenue of 187.02M TWD with 10.00% growth. Gwo Xi Stem Cell Applied Technology Co. , had revenue of 92.53M in the half year ending December 31, 2025, with 30.53% growth.
Revenue
187.02M
Revenue Growth
+10.00%
P/S Ratio
11.57
Revenue / Employee
3.40M
Employees
55
Market Cap
2.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 187.02M | 17.00M | 10.00% |
| Dec 31, 2024 | 170.03M | 28.85M | 20.44% |
| Dec 31, 2023 | 141.18M | -39.49M | -21.86% |
| Dec 31, 2022 | 180.67M | -62.09M | -25.58% |
| Dec 31, 2021 | 242.75M | 54.21M | 28.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.04B |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| Genomics BioSci & Tech. | 708.38M |
| G&E Herbal Biotechnology | 309.13M |
| Sunny Pharmtech | 290.18M |
| 3D Global Biotech | 206.74M |
| GlycoNex Incorporation | 37.86M |
| TaiRx | 27.88M |